To provide a substituted imidazo[1,2B]pyridazine compound as a TRK kinase inhibitor.
A compound of a formula I, where R1, R2, R3, R4, X, Y and n have meanings described in the description, is an inhibitor of Trk kinase and is useful for treatment of diseases which can be treated by the Trk kinase inhibitor. There is also provided a pharmaceutical composition containing the compound, a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable diluent or carrier. There is also provided a method for treatment of pain, cancer, inflammation, neurodegenerative diseases or Trypanosoma cruzi infection in mammalian including administering therapeutically effective amount of the compound or the pharmaceutically acceptable salt thereof to the mammalian.
JULIA HAAS
JIANG YUTONG
ZHANG GAN
JP2012503018A | 2012-02-02 | |||
JP2013537199A | 2013-09-30 |
Natsuki Morishita